Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04473482 · ClinicalTrials.gov registry record · NA
Michigan Alcohol Improvement Network- Alcohol Reduction and Treatment Trial
A NA study of Liver Diseases and Alcohol-Related Disorders, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT04473482: Completed NA study of Liver Diseases and Alcohol-Related Disorders, sponsored by University of Michigan.
NCT04473482 is a NA study of Liver Diseases and Alcohol-Related Disorders that has completed, run by University of Michigan. The registered enrollment target is 60 participants, below the 61,157-participant average among 33 other Liver Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04473482, a NA study of Liver Diseases and Alcohol-Related Disorders, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to determine if providing participants with alcohol-related liver disease with tailored alcohol use treatment options is feasible and acceptable in order to increase their engagement with treatment and reduce alcohol use. This is an important area to study to help create ways to increase participants' knowledge about different treatment options as well as increase likelihood of seeking and participating in alcohol use disorder treatments.
Primary Outcome
Feasibility of administration of the MAIN-ART tool will be determined by recruitment rates and retention rates (as measured at 6 months after recruitment). Study recruitment started on 23 September, 2020 and concluded on 10 January 2022. The results reflect the number and percent of those patients who were approached, were determined to be eligible, and were consented.
Conditions Studied
Interventions
- BEHAVIORAL Michigan Alcohol Improvement Network-Alcohol Reduction and Treatment tool
Study Locations (1)
Michigan
- The University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2020-09-23 |
| Est. Completion | 2022-06-30 |
| Phase | NA |
What the finished NCT04473482 record still lists
NCT04473482 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 61,157-participant average among 33 other Liver Diseases trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Liver Diseases appearing as the primary indexed condition, and to 1 intervention - of which Michigan Alcohol Improvement Network-Alcohol Reduction and Treatment tool is the first listed.
NCT04473482 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT04473482 about?
NCT04473482 is a clinical study titled "Michigan Alcohol Improvement Network- Alcohol Reduction and Treatment Trial". The purpose of the study is to determine if providing participants with alcohol-related liver disease with tailored alcohol use treatment options is feasible and acceptable in order to increase their engagement with treatment and reduce alcohol use. This is an important area to study to help create ...
What is the current status of trial NCT04473482?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2020-09-23. Estimated completion is 2022-06-30.
What conditions does trial NCT04473482 study?
This clinical trial studies the following conditions: Liver Diseases, Alcohol-Related Disorders.
What interventions are being tested in trial NCT04473482?
The interventions under investigation include: Michigan Alcohol Improvement Network-Alcohol Reduction and Treatment tool (BEHAVIORAL).
Who is sponsoring clinical trial NCT04473482?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04473482 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04473482's enrollment target sits among peer trials
60 22nd of 33 higher than 12 of 33 other Liver Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Liver Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Veteran-Centered Care for Advanced Liver Disease (Vet-CALD)
RECRUITING · NA
-
Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients
RECRUITING · NA
-
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
RECRUITING · NA
-
A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease
RECRUITING · NA
-
Safety and Efficacy of Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement
RECRUITING · NA
-
Liver Cancer Prevention Randomized Control Trial
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI